These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 8425606)
1. Effect of platelet activating factor on the kinetics of LDL oxidation in vitro. Deigner HP; Dresel HA FEBS Lett; 1993 Feb; 317(3):202-6. PubMed ID: 8425606 [TBL] [Abstract][Full Text] [Related]
2. Platelet-activating factor acetylhydrolase and transacetylase activities in human plasma low-density lipoprotein. Tsoukatos DC; Liapikos TA; Tselepis AD; Chapman MJ; Ninio E Biochem J; 2001 Jul; 357(Pt 2):457-64. PubMed ID: 11439095 [TBL] [Abstract][Full Text] [Related]
3. Molecular and mechanistic characterization of platelet-activating factor-like bioactivity produced upon LDL oxidation. Androulakis N; Durand H; Ninio E; Tsoukatos DC J Lipid Res; 2005 Sep; 46(9):1923-32. PubMed ID: 15995176 [TBL] [Abstract][Full Text] [Related]
4. Oxidatively fragmented phosphatidylcholines activate human neutrophils through the receptor for platelet-activating factor. Smiley PL; Stremler KE; Prescott SM; Zimmerman GA; McIntyre TM J Biol Chem; 1991 Jun; 266(17):11104-10. PubMed ID: 1645725 [TBL] [Abstract][Full Text] [Related]
5. 1 Acyl-2 acetyl-sn-glycero-3 phosphocholine decreases the susceptibility of low-density lipoprotein to oxidative modification by copper ions, monocytes or endothelial cells. Maziere C; Djavahery-Mergny M; Auclair M; Maziere JC Biochim Biophys Acta; 1994 Jan; 1210(2):233-8. PubMed ID: 8280775 [TBL] [Abstract][Full Text] [Related]
7. Platelet-activating factor formation during oxidative modification of low-density lipoprotein when PAF-acetylhydrolase has been inactivated. Liapikos TA; Antonopoulou S; Karabina SP; Tsoukatos DC; Demopoulos CA; Tselepis AD Biochim Biophys Acta; 1994 Jun; 1212(3):353-60. PubMed ID: 8199206 [TBL] [Abstract][Full Text] [Related]
8. Lipid peroxidation in low density lipoproteins from human plasma and egg yolk promotes accumulation of 1-acyl analogues of platelet-activating factor-like lipids. Tokumura A; Toujima M; Yoshioka Y; Fukuzawa K Lipids; 1996 Dec; 31(12):1251-8. PubMed ID: 8972457 [TBL] [Abstract][Full Text] [Related]
9. Metabolism of platelet-activating factor (PAF; 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) and lyso-PAF (1-O-alkyl-2-lyso-sn-glycero-3-phosphocholine) by cultured rat Kupffer cells. Chao W; Siafaka-Kapadai A; Hanahan DJ; Olson MS Biochem J; 1989 Jul; 261(1):77-81. PubMed ID: 2775221 [TBL] [Abstract][Full Text] [Related]
10. A Penicillium sp. F33 metabolite and its synthetic derivatives inhibit acetyl-CoA:1-O-alkyl-sn-glycero-3-phosphocholine acetyltransferase (a key enzyme in platelet-activating factor biosynthesis) and carrageenan-induced paw edema in mice. Yamazaki Y; Yasuda K; Matsuyama T; Ishihara T; Higa R; Sawairi T; Yamaguchi M; Egi M; Akai S; Miyase T; Ikari A; Miwa M; Sugatani J Biochem Pharmacol; 2013 Sep; 86(5):632-44. PubMed ID: 23817078 [TBL] [Abstract][Full Text] [Related]